|
Philips identified a software defect internally in intellispace cardiovascular (iscv) whereby the thick client application does not adequately distinguish between legitimate and malicious dynamic link library (.Dll) files.A malicious dll could potentially be placed in a higher-priority search location and subsequently loaded and executed by the application when a dll with a matching name is found.The device was not in clinical use at the time of the event, and no adverse events or harm were reported in the complaint (pr (b)(4).\
\
the investigation revealed that an exploitation of this weakness could allow the attacker to further compromise iscv thick client, deploy malware, or make iscv client unavailable.If iscv behavior is altered, users may be shown incorrect, incomplete, or misleading information and in worst case also make iscv unavailable.\
\
a risk assessment was performed and determined that this affects core clinical workflow functions that depend on timely access to accurate patient information.The issue is not readily recoverable by clinicians, and no workaround exists to maintain system availability or verify data integrity following exploitation.The resulting loss of access to clinical information or use of incorrect patient data may potentially lead to a delayed diagnosis.Based on the available information, this issue is determined to be a reportable malfunction.
|